Pharmaceutical Access in Brazil: Challenges and Opportunities

In this review of pharmaceutical access in Brazil, the authors note that the Brazilian pharmaceutical market is highly concentrated, with low investment in R&D and heavy reliance on imported active ingredients. High drug prices and drug shortages also contribute to inequities in patient access. Prioritizing R&D investment, reducing dependency on international markets, and other reforms to drug pricing and patent standards can help alleviate these access challenges.